#ARCoV - Twitter Hashtag

FOOTBALL ARENA XXTRA

@ChelseaUpgrade

about 2 months ago

Arsenal 3-0 Coventry City Premier League Review #Arsenal #Coventry #ARCOV

3

54

30

0

661

Gracie💙

@Gracie_Blue89

about 2 months ago

That was THE WORST opening game of a season that I have ever seen Commiserations to Coventry, I know Super Frank will keep you up Good luck!! #ARCOV

17

42

2

0

1K

Spektrum @spektrum

over 4 years ago

Ob Chinas #ARCoV-Impfstoff offiziell zugelassen wird, hängt von den Ergebnissen der Phase-III-Studie ab. Und selbst wenn die Behörden sich dafür aussprechen, sind zeitnahe Corona-Lockerungen im Land fraglich. #COVID #Coronavirus #ZeroCovid https://t.co/2illhpuycu

0

4

2

0

MicrobesInfect @MicrobesInfect

over 4 years ago

China is progressing towards approving #ArCoV, its first mRNA vaccine against #COVID19. In a small clinical trial, ArCoV booster shot seemed to trigger a stronger antibody response than inactivated-virus vaccine of the type that the country has relied on https://t.co/PI9VBxoA5K

0

9

2

0

El Financiero

@ElFinanciero_Mx

over 4 years ago

#ARCoV podría convertirse en la próxima vacuna de ARN mensajero desarrollada por #China. https://t.co/tIurLZKiHO

0

2

0

1

0

Detaileinsammler 💉💉💉 @Outist2

over 4 years ago

#Plötzlichunderwartet werden durch bessere #Corona-#Impfstoofe wie #ArCoV, keine Menschen mehr an den #Impfnebenwirkungen sterben, was die #Impfgegner bestimmt ganz traurig macht, da sie dann nicht mehr trollen können. https://t.co/BziTKlNKYp

Detaileinsammler 💉💉💉 @Outist2

over 5 years ago

@Jasonvj2005 Anmerkung: Mit "Spike-Protein-freien-#Impfstoff" meine ich welchen wo höchstens die Rezeptor-Bindungs-Domäne und nicht das ganze #SpikeProtein drin ist, da sollen nach https://t.co/AQuusm5iiW die Probleme nicht auftreten.

0

1

0

Jerome Kim @drjeromekim1

over 4 years ago

Whether China’s homegrown mRNA vaccine #ARCoV will be successful will depend on safety, efficacy and immuno. A non-inferiority study will give more information about its performance compared to existing mRNA vaccines. Read full @SCMPNews article here: https://t.co/fN7wE1IEKx

1

3

0

Dongsheng News @DongshengNews

over 4 years ago

@caixin Jointly developed by #Walvax Biotechnology, #Suzhou Abogen Biosciences, and the #PLA Academy of Military Science, #ARCoV vaccine is the first homegrown mRNA to enter Phase III trials and can be stored at standard refrigerated conditions (2-8°C)...

1

3

0

CGTN BIZ

@CGTNGlobalBiz

over 4 years ago

A study published Tuesday in the #Lancet Microbe journal confirmed the #safety, tolerability, and immunogenicity profile of the #China-made #COVID19 #mRNA vaccine, #ARCoV. (1/3)

1

7

5

0

People's Daily, China

@PDChina

over 4 years ago

Two shots of #ARCoV, China's first domestic mRNA vaccine candidate against the #COVID19, show seroconversion rates ranging from 80% to 95%, according to latest report on Phase I clinical trials published recently on The Lancet. https://t.co/0vm82DPyqz

PDChina's tweet photo. Two shots of #ARCoV, China's first domestic mRNA vaccine candidate against the #COVID19, show seroconversion rates ranging from 80% to 95%, according to latest report on Phase I clinical trials published recently on The Lancet. https://t.co/0vm82DPyqz https://t.co/tXJOrZRC95

2

12

16

0

Global Times

@globaltimesnews

over 4 years ago

Two shots of #ARCoV, China's first domestic #mRNA COVID-19 #vaccine, show seroconversion rates ranging from 80 to 95%, according to latest report on Phase I clinical trials published recently on The Lancet. https://t.co/iqhps6Wabz

globaltimesnews's tweet photo. Two shots of #ARCoV, China's first domestic #mRNA COVID-19 #vaccine, show seroconversion rates ranging from 80 to 95%, according to latest report on Phase I clinical trials published recently on The Lancet. https://t.co/iqhps6Wabz https://t.co/8uhxuQIuKC

3

49

21

1

0

The Lancet Microbe @LancetMicrobe

over 4 years ago

New research article> Safety and immunogenicity of the #SARSCoV2 #ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial https://t.co/JUoGvG5Xx0 #COVID19

0

4

1

0

People's Daily, China

@PDChina

over 5 years ago

China's first #mRNA #COVID19 vaccine #ARCoV will start its Phase III clinical trial overseas in May, China National Radio (CNR) has reported. Starting from the 3rd quarter of the year, the annual production capacity of ARCoV will reach 120 million doses.

PDChina's tweet photo. China's first #mRNA #COVID19 vaccine #ARCoV will start its Phase III clinical trial overseas in May, China National Radio (CNR) has reported. Starting from the 3rd quarter of the year, the annual production capacity of ARCoV will reach 120 million doses. https://t.co/Eq0lVqhzxB

1

34

9

2

0

LIGA.net @LIGAnet

almost 6 years ago

В Китае создали и проверяют #ARCoV — аналог вакцин #Moderna и #PfizerBioNTech: говорят о важных преимуществах препарата #коронавирус #вирус #SARS_CoV_2 #SARSCoV2 #COVID19 #COVID_19 #медицина #наука #исследование #вакцина #вакцинация #прививка #Walvax https://t.co/acuUreK573

1

2

1

0

Xavier Abad MdG🎗 @XavierAbadMdG

about 6 years ago

Xina també té el seu prototip de vacuna genètica, per AMMS-Abogen-Walvax. #ARCoV ha estat aprovada (?) per assajos en humans; fase 1 ja iniciada, vacuna 1 sola dosi; es proclama 1 setmana estable a temp. ambient; de confirmar-se seria gran avantatge logístic però, en fi, és Xina.

1

2

0

Cell Press @CellPressNews

about 6 years ago

Newly developed #ARCoV, a thermostable LNP-encapsulated mRNA vaccine platform, mounts a strong immune response in both mice and non-human primates, even protecting against #SARSCoV2 in mice. Read more at @CellCellPress https://t.co/od1X0qWFn3

CellPressNews's tweet photo. Newly developed #ARCoV, a thermostable LNP-encapsulated mRNA vaccine platform, mounts a strong immune response in both mice and non-human primates, even protecting against #SARSCoV2 in mice. Read more at @CellCellPress https://t.co/od1X0qWFn3 https://t.co/53iguH8JYy

0

10

6

1

0

Cell Press @CellPressNews

about 6 years ago

Researchers developed a #SARSCoV2 vaccine using lipid-nanoparticle-encapusulated-mRNA, #ARCoV. So far, this vaccine has been shown to offer complete protection from SARS-CoV-2 in mice @CellCellPress https://t.co/qaE3MIZ1cd

CellPressNews's tweet photo. Researchers developed a #SARSCoV2 vaccine using lipid-nanoparticle-encapusulated-mRNA, #ARCoV. So far, this vaccine has been shown to offer complete protection from SARS-CoV-2 in mice @CellCellPress https://t.co/qaE3MIZ1cd https://t.co/CNvDaDTKoD

0

35

8

3

0

ISGlobal

@ISGLOBALorg

about 6 years ago

💉 La vacuna china #ARCoV indujo un buen nivel de anticuerpos neutralizantes contra el virus y una buena respuesta celular en ratones y primates no humanos. 💉 La vacuna de #Moderna protegió a macacos de la inflamación y daño pulmonar cuando fueron expuestos al virus.

ISGLOBALorg's tweet photo. 💉 La vacuna china #ARCoV indujo un buen nivel de anticuerpos neutralizantes contra el virus y una buena respuesta celular en ratones y primates no humanos.

💉 La vacuna de #Moderna protegió a macacos de la inflamación y daño pulmonar cuando fueron expuestos al virus. https://t.co/pxV6YZW6ne

1

5

0

Top Tweets for #ARCoV

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users